Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms

Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms

Background: The clinical management of high-grade gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) is challenging due to disease heterogeneity, illustrating the need for reliable biomarkers facilitating patient stratification and guiding treatment decisions. FMS-like tyrosine kinase 3 ligan...

Full description

Bibliographic Details
Main Authors: Katharina M. Detjen, Raik Otto, Yvonne Giesecke, Lukas Geisler, Pamela Riemer, Henning Jann, Carsten Grötzinger, Christine Sers, Andreas Pascher, Tom Lüdde, Ulf Leser, Bertram Wiedenmann, Michael Sigal, Frank Tacke, Christoph Roderburg, Linda Hammerich
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
neuroendocrine neoplasm
immuno-oncology
tumor microenvironment
circulating biomarker
Flt3L
cytokine
Online Access:https://www.mdpi.com/2072-6694/13/17/4463

Internet

https://www.mdpi.com/2072-6694/13/17/4463

Similar Items